Conversely, BSCs from COVID‐19 patients exhibited a proclivity for differentiation into goblet cell‐enriched epithelium, predominantly expressing MUC5AC, indicative of goblet cell hyperplasia (Figure 1F). Here, MUC5AC is linked to COVID-19.